Compare EXR & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXR | IQV |
|---|---|---|
| Founded | 1977 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.3B | 35.1B |
| IPO Year | 2004 | 2013 |
| Metric | EXR | IQV |
|---|---|---|
| Price | $140.06 | $260.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 16 |
| Target Price | $144.80 | ★ $227.13 |
| AVG Volume (30 Days) | 761.6K | ★ 1.2M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | ★ 13.90 | 4.67 |
| EPS | ★ 2.39 | 1.61 |
| Revenue | $3,377,542,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | $3.63 | $5.89 |
| P/E Ratio | ★ $58.23 | $161.00 |
| Revenue Growth | 3.70 | ★ 41.60 |
| 52 Week Low | $125.71 | $154.50 |
| 52 Week High | $158.88 | $271.80 |
| Indicator | EXR | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 62.56 |
| Support Level | $139.88 | $218.57 |
| Resistance Level | $146.69 | N/A |
| Average True Range (ATR) | 2.30 | 7.38 |
| MACD | -0.61 | -0.78 |
| Stochastic Oscillator | 16.60 | 67.41 |
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages more than 4,200 self-storage properties in 43 states, with over 330 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.